Covid-19: Kenya to use Japanese flu drug for treatment
In Summary
Kenya is in discussion with Japan to receive batches of the antiviral drug, called Favipiravir or Avigan.
Favipiravir was originally developed to treat influenza by Toyama Chemical
by MAGDALINE SAYA News
Acting Director of Health Patrick Amoth
said the government was in discussion with Japan to receive batches of the antiviral drug, called Favipiravir or Avigan.
The drug has been used for years in Japan to treat influenza and, last month, it was approved as an experimental treatment for Covid-19.
We are in discussion with the government of Japan who have developed an antiviral which has shown very good promise,
so that we can get some doses that our physicians can also be able to try for Covid-19.
And we are hopeful that we will also tell our results like what they have done in Japan and China,Amoth told journalists yesterday.